Back
Climb Bio, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
CLYM
Climb Bio, Inc.
Last Price:
$4.94
Seasonality Move:
-22.23%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLYM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Climb Bio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.5 | Buy |
| 20-day SMA: | 2.97 | Buy |
| 50-day SMA: | 2.36 | Buy |
| 200-day SMA: | 1.75 | Buy |
| 8-day EMA: | 4.33 | Buy |
| 20-day EMA: | 3.41 | Buy |
| 50-day EMA: | 2.64 | Buy |
| 200-day EMA: | 1.48 | Buy |
Climb Bio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 77.46 | Buy |
| Chaikin Money Flow: | 667721 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.47 - 3.99) | Buy |
| Bollinger Bands (100): | (1.5 - 2.94) | Buy |
Climb Bio, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Climb Bio, Inc. Stock
Is Climb Bio, Inc. Stock a Buy?
-
Climb Bio, Inc. share price is 4.93 while CLYM 8-day simple moving average is 4.50, which is a Buy signal.
-
The stock price of CLYM is 4.93 while Climb Bio, Inc. 20-day SMA is 2.97, which makes it a Buy.
-
Climb Bio, Inc. 50-day simple moving average is 2.36 while CLYM share price is 4.93, making it a Buy technically.
-
CLYM stock price is 4.93 and Climb Bio, Inc. 200-day simple moving average is 1.75, creating a Buy signal.
CLYM Technical Analysis vs Fundamental Analysis
Buy
55
Climb Bio, Inc. (CLYM)
is a Buy
Is Climb Bio, Inc. a Buy or a Sell?
-
Climb Bio, Inc. stock is rated a BuyThe current Climb Bio, Inc. [CLYM] share price is $4.93. The Score for CLYM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Climb Bio, Inc. Stock Info
Market Cap:
336.1M
Price in USD:
4.93
Share Volume:
774.6K
Climb Bio, Inc. 52-Week Range
52-Week High:
5.05
52-Week Low:
1.05
Buy
55
Climb Bio, Inc. (CLYM)
is a Buy
Climb Bio, Inc. Share Price Forecast
-
What is the Climb Bio, Inc. stock price today?The Climb Bio, Inc. stock price is 4.93 USD today.
-
Will CLYM stock go up or go down?Climb Bio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Climb Bio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Climb Bio, Inc. is not overvalued.
Is Climb Bio, Inc. Stock a Buy?
-
Climb Bio, Inc. share price is 4.93 while CLYM 8-day exponential moving average is 4.33, which is a Buy signal.
-
The stock price of CLYM is 4.93 while Climb Bio, Inc. 20-day EMA is 3.41, which makes it a Buy.
-
Climb Bio, Inc. 50-day exponential moving average is 2.64 while CLYM share price is 4.93, making it a Buy technically.
-
CLYM stock price is 4.93 and Climb Bio, Inc. 200-day simple moving average is 1.48, creating a Buy signal.
Fundamental Analysis of Climb Bio, Inc.
Is Climb Bio, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Climb Bio, Inc.
Should I short Climb Bio, Inc. stock?
-
CLYM Moving Average Covergence Divergence (MACD) indicator is 0.79, suggesting Climb Bio, Inc. is a Buy
-
Climb Bio, Inc. Relative Strength Index (RSI) is 77.46, which suggest Climb Bio, Inc. is overbought
-
The Bollinger Bands (25) for Climb Bio, Inc. is (1.47 - 3.99), which suggest Climb Bio, Inc. is a Buy
-
The Bollinger Bands (100) for Climb Bio, Inc. is (1.5 - 2.94), which suggest Climb Bio, Inc. is a Buy
* Climb Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.